Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2021-12-17 to 2022-01-11
Current total value of award: $3640.8
Description: 4555797963!ZOLADEX 3.6 MG IMPLANT SYRNS